(3-((4-Methylpiperazin-1-yl)Methyl)phenyl)boronic acid
95%
- Product Code: 36622
CAS:
1171044-16-8
| Molecular Weight: | 234.10 g./mol | Molecular Formula: | C₁₂H₁₉BN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16198076 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃, dry, airtight |
Product Description:
This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of pharmaceutical agents. Its boronic acid functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in the synthesis of complex organic molecules, including drugs and bioactive compounds. Additionally, the presence of the 4-methylpiperazine moiety enhances its potential in designing molecules with improved pharmacokinetic properties, such as solubility and bioavailability. It is particularly relevant in the synthesis of targeted therapies, including kinase inhibitors and other small-molecule drugs for treating diseases like cancer and inflammatory disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $83.27 |
+
-
|
| 0.250 | 10-20 days | $278.54 |
+
-
|
| 1.000 | 10-20 days | $676.28 |
+
-
|
(3-((4-Methylpiperazin-1-yl)Methyl)phenyl)boronic acid
This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of pharmaceutical agents. Its boronic acid functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in the synthesis of complex organic molecules, including drugs and bioactive compounds. Additionally, the presence of the 4-methylpiperazine moiety enhances its potential in designing molecules with improved pharmacokinetic properties, such as solubility and bioavailability. It is particularly relevant in the synthesis of targeted therapies, including kinase inhibitors and other small-molecule drugs for treating diseases like cancer and inflammatory disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :